Titre : Tumeurs de l'appareil digestif

Tumeurs de l'appareil digestif : Questions médicales fréquentes

Termes MeSH sélectionnés :

Network Meta-Analysis
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Tumeurs de l'appareil digestif : Questions médicales les plus fréquentes", "headline": "Tumeurs de l'appareil digestif : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Tumeurs de l'appareil digestif : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-21", "dateModified": "2025-02-15", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Tumeurs de l'appareil digestif" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Maladies de l'appareil digestif", "url": "https://questionsmedicales.fr/mesh/D004066", "about": { "@type": "MedicalCondition", "name": "Maladies de l'appareil digestif", "code": { "@type": "MedicalCode", "code": "D004066", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C06" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Tumeurs des voies biliaires", "alternateName": "Biliary Tract Neoplasms", "url": "https://questionsmedicales.fr/mesh/D001661", "about": { "@type": "MedicalCondition", "name": "Tumeurs des voies biliaires", "code": { "@type": "MedicalCode", "code": "D001661", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C06.301.120" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Tumeurs des canaux biliaires", "alternateName": "Bile Duct Neoplasms", "url": "https://questionsmedicales.fr/mesh/D001650", "about": { "@type": "MedicalCondition", "name": "Tumeurs des canaux biliaires", "code": { "@type": "MedicalCode", "code": "D001650", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C06.301.120.250" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Tumeurs du cholédoque", "alternateName": "Common Bile Duct Neoplasms", "url": "https://questionsmedicales.fr/mesh/D003138", "about": { "@type": "MedicalCondition", "name": "Tumeurs du cholédoque", "code": { "@type": "MedicalCode", "code": "D003138", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C06.301.120.250.250" } } } ] }, { "@type": "MedicalWebPage", "name": "Tumeurs du cholédoque", "alternateName": "Common Bile Duct Neoplasms", "url": "https://questionsmedicales.fr/mesh/D003138", "about": { "@type": "MedicalCondition", "name": "Tumeurs du cholédoque", "code": { "@type": "MedicalCode", "code": "D003138", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C06.301.120.250.250" } } }, { "@type": "MedicalWebPage", "name": "Tumeurs de la vésicule biliaire", "alternateName": "Gallbladder Neoplasms", "url": "https://questionsmedicales.fr/mesh/D005706", "about": { "@type": "MedicalCondition", "name": "Tumeurs de la vésicule biliaire", "code": { "@type": "MedicalCode", "code": "D005706", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C06.301.120.401" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Tumeurs de l'appareil digestif", "alternateName": "Digestive System Neoplasms", "code": { "@type": "MedicalCode", "code": "D004067", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Anne Couvelard", "url": "https://questionsmedicales.fr/author/Anne%20Couvelard", "affiliation": { "@type": "Organization", "name": "Department of Pathology, Beaujon/Bichat Hospitals (APHP.Nord), Université Paris-Cité, Clichy/Paris, France." } }, { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Jérôme Cros", "url": "https://questionsmedicales.fr/author/J%C3%A9r%C3%B4me%20Cros", "affiliation": { "@type": "Organization", "name": "Department of Pathology, Beaujon/Bichat Hospitals (APHP.Nord), Université Paris-Cité, Clichy/Paris, France." } }, { "@type": "Person", "name": "Jinbo Liu", "url": "https://questionsmedicales.fr/author/Jinbo%20Liu", "affiliation": { "@type": "Organization", "name": "Department of Clinical Laboratory, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China. Electronic address: liulab2019@163.com." } }, { "@type": "Person", "name": "Guido Rindi", "url": "https://questionsmedicales.fr/author/Guido%20Rindi", "affiliation": { "@type": "Organization", "name": "Anatomic Pathology Section, Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, Roma, Italy." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Tocolytics for delaying preterm birth: a network meta-analysis (0924).", "datePublished": "2022-08-10", "url": "https://questionsmedicales.fr/article/35947046", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/14651858.CD014978.pub2" } }, { "@type": "ScholarlyArticle", "name": "Bayesian unanchored additive models for component network meta-analysis.", "datePublished": "2022-07-17", "url": "https://questionsmedicales.fr/article/35844085", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/sim.9520" } }, { "@type": "ScholarlyArticle", "name": "Pharmacological treatments in panic disorder in adults: a network meta-analysis.", "datePublished": "2023-11-28", "url": "https://questionsmedicales.fr/article/38014714", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/14651858.CD012729.pub3" } }, { "@type": "ScholarlyArticle", "name": "Thresholds for surfactant use in preterm neonates: a network meta-analysis.", "datePublished": "2022-12-09", "url": "https://questionsmedicales.fr/article/36600484", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/archdischild-2022-324184" } }, { "@type": "ScholarlyArticle", "name": "Cardiotoxicity of immune checkpoint inhibitors: A frequency network meta-analysis.", "datePublished": "2022-09-14", "url": "https://questionsmedicales.fr/article/36189211", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fimmu.2022.1006860" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies de l'appareil digestif", "item": "https://questionsmedicales.fr/mesh/D004066" }, { "@type": "ListItem", "position": 3, "name": "Tumeurs de l'appareil digestif", "item": "https://questionsmedicales.fr/mesh/D004067" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Tumeurs de l'appareil digestif - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Tumeurs de l'appareil digestif", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-07", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Tumeurs de l'appareil digestif", "description": "Comment diagnostiquer une tumeur digestive ?\nQuels tests sanguins sont utilisés ?\nQuelle est l'importance de l'endoscopie ?\nQuand faire un scanner abdominal ?\nQuels symptômes nécessitent un diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D004067?mesh_terms=Network+Meta-Analysis&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Tumeurs de l'appareil digestif", "description": "Quels sont les symptômes courants des tumeurs digestives ?\nComment se manifeste une obstruction intestinale ?\nLes tumeurs peuvent-elles causer des saignements ?\nQuels signes indiquent une tumeur de l'estomac ?\nLes tumeurs peuvent-elles provoquer des troubles digestifs ?", "url": "https://questionsmedicales.fr/mesh/D004067?mesh_terms=Network+Meta-Analysis&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Tumeurs de l'appareil digestif", "description": "Comment prévenir les tumeurs digestives ?\nLe dépistage est-il important ?\nQuels aliments éviter pour réduire le risque ?\nLe surpoids est-il un facteur de risque ?\nFaut-il éviter l'alcool ?", "url": "https://questionsmedicales.fr/mesh/D004067?mesh_terms=Network+Meta-Analysis&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Tumeurs de l'appareil digestif", "description": "Quels traitements sont disponibles pour les tumeurs digestives ?\nQuand la chirurgie est-elle recommandée ?\nQuel rôle joue la chimiothérapie ?\nLa radiothérapie est-elle efficace ?\nQu'est-ce que l'immunothérapie ?", "url": "https://questionsmedicales.fr/mesh/D004067?mesh_terms=Network+Meta-Analysis&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Tumeurs de l'appareil digestif", "description": "Quelles sont les complications possibles des tumeurs digestives ?\nComment les tumeurs affectent-elles la nutrition ?\nLes tumeurs peuvent-elles causer des douleurs chroniques ?\nQuelles sont les conséquences des métastases ?\nLes infections sont-elles une complication ?", "url": "https://questionsmedicales.fr/mesh/D004067?mesh_terms=Network+Meta-Analysis&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Tumeurs de l'appareil digestif", "description": "Quels sont les principaux facteurs de risque ?\nLe tabagisme augmente-t-il le risque ?\nLes antécédents familiaux sont-ils importants ?\nL'alimentation joue-t-elle un rôle ?\nLe stress est-il un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D004067?mesh_terms=Network+Meta-Analysis&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une tumeur digestive ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par endoscopie, imageries (IRM, scanner) et biopsie." } }, { "@type": "Question", "name": "Quels tests sanguins sont utilisés ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des marqueurs tumoraux comme le CEA et l'AFP peuvent être mesurés." } }, { "@type": "Question", "name": "Quelle est l'importance de l'endoscopie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "L'endoscopie permet de visualiser directement les lésions et de prélever des échantillons." } }, { "@type": "Question", "name": "Quand faire un scanner abdominal ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Un scanner est recommandé pour évaluer l'extension de la tumeur et les métastases." } }, { "@type": "Question", "name": "Quels symptômes nécessitent un diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs abdominales persistantes, des saignements ou des changements de transit." } }, { "@type": "Question", "name": "Quels sont les symptômes courants des tumeurs digestives ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent douleurs abdominales, perte de poids, nausées et vomissements." } }, { "@type": "Question", "name": "Comment se manifeste une obstruction intestinale ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elle se manifeste par des douleurs, des vomissements et une incapacité à évacuer les selles." } }, { "@type": "Question", "name": "Les tumeurs peuvent-elles causer des saignements ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des saignements peuvent survenir dans les selles ou par voie orale selon la localisation." } }, { "@type": "Question", "name": "Quels signes indiquent une tumeur de l'estomac ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs épigastriques, des nausées, et une sensation de satiété précoce peuvent indiquer une tumeur." } }, { "@type": "Question", "name": "Les tumeurs peuvent-elles provoquer des troubles digestifs ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent entraîner des troubles comme des ballonnements, des diarrhées ou de la constipation." } }, { "@type": "Question", "name": "Comment prévenir les tumeurs digestives ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée, l'exercice régulier et l'évitement du tabac sont conseillés." } }, { "@type": "Question", "name": "Le dépistage est-il important ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le dépistage précoce peut aider à détecter les tumeurs à un stade précoce." } }, { "@type": "Question", "name": "Quels aliments éviter pour réduire le risque ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Il est conseillé de limiter les viandes transformées et les aliments riches en graisses saturées." } }, { "@type": "Question", "name": "Le surpoids est-il un facteur de risque ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'obésité est un facteur de risque pour plusieurs types de tumeurs digestives." } }, { "@type": "Question", "name": "Faut-il éviter l'alcool ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une consommation excessive d'alcool augmente le risque de cancers digestifs." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les tumeurs digestives ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la chirurgie, la chimiothérapie et la radiothérapie." } }, { "@type": "Question", "name": "Quand la chirurgie est-elle recommandée ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La chirurgie est souvent recommandée pour retirer la tumeur si elle est localisée." } }, { "@type": "Question", "name": "Quel rôle joue la chimiothérapie ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La chimiothérapie est utilisée pour réduire la taille des tumeurs ou traiter les métastases." } }, { "@type": "Question", "name": "La radiothérapie est-elle efficace ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut être utilisée pour traiter les tumeurs non opérables ou réduire la douleur." } }, { "@type": "Question", "name": "Qu'est-ce que l'immunothérapie ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "L'immunothérapie stimule le système immunitaire pour combattre les cellules tumorales." } }, { "@type": "Question", "name": "Quelles sont les complications possibles des tumeurs digestives ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des saignements, des obstructions intestinales et des métastases." } }, { "@type": "Question", "name": "Comment les tumeurs affectent-elles la nutrition ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent provoquer des malabsorption et des carences nutritionnelles." } }, { "@type": "Question", "name": "Les tumeurs peuvent-elles causer des douleurs chroniques ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent entraîner des douleurs chroniques dues à l'invasion des tissus environnants." } }, { "@type": "Question", "name": "Quelles sont les conséquences des métastases ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les métastases peuvent affecter d'autres organes, compliquant le traitement et le pronostic." } }, { "@type": "Question", "name": "Les infections sont-elles une complication ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les infections peuvent survenir, surtout après une chirurgie ou en cas d'immunosuppression." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge, les antécédents familiaux, le tabagisme et l'alimentation." } }, { "@type": "Question", "name": "Le tabagisme augmente-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme est un facteur de risque reconnu pour plusieurs cancers digestifs." } }, { "@type": "Question", "name": "Les antécédents familiaux sont-ils importants ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de cancers digestifs augmentent le risque individuel." } }, { "@type": "Question", "name": "L'alimentation joue-t-elle un rôle ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en fibres et pauvre en graisses peut réduire le risque." } }, { "@type": "Question", "name": "Le stress est-il un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Le stress n'est pas un facteur direct, mais il peut influencer des comportements à risque." } } ] } ] }

Sources (10000 au total)

Tocolytics for delaying preterm birth: a network meta-analysis (0924).

Preterm birth is the leading cause of death in newborns and children. Tocolytic drugs aim to delay preterm birth by suppressing uterine contractions to allow time for administration of corticosteroids... To estimate relative effectiveness and safety profiles for different classes of tocolytic drugs for delaying preterm birth, and provide rankings of the available drugs.... We searched Cochrane Pregnancy and Childbirth's Trials Register, ClinicalTrials.gov (21 April 2021) and reference lists of retrieved studies.... We included all randomised controlled trials assessing effectiveness or adverse effects of tocolytic drugs for delaying preterm birth. We excluded quasi- and non-randomised trials. We evaluated all st... At least two review authors independently assessed the trials for inclusion and risk of bias, and extracted data. We performed pairwise and network meta-analyses, to determine the relative effects and... This network meta-analysis includes 122 trials (13,697 women) involving six tocolytic classes, combinations of tocolytics, and placebo or no treatment. Most trials included women with threatened prete... Compared with placebo or no tocolytic treatment, all tocolytic drug classes that we assessed (betamimetics, calcium channel blockers, magnesium sulphate, oxytocin receptor antagonists, nitric oxide do...

Pharmacological treatments in panic disorder in adults: a network meta-analysis.

A panic attack is a discrete period of fear or anxiety that has a rapid onset and reaches a peak within 10 minutes. The main symptoms involve bodily systems, such as racing heart, chest pain, sweating... To compare, via network meta-analysis, individual drugs (antidepressants and benzodiazepines) or placebo in terms of efficacy and acceptability in the acute treatment of panic disorder, with or withou... We searched the Cochrane Common Mental Disorders Specialised Register, CENTRAL, CDSR, MEDLINE, Ovid Embase and PsycINFO to 26 May 2022.... We included randomised controlled trials (RCTs) of people aged 18 years or older of either sex and any ethnicity with clinically diagnosed panic disorder, with or without agoraphobia. We included tria... Two authors independently screened titles/abstracts and full texts, extracted data and assessed risk of bias. We analysed dichotomous data and continuous data as risk ratios (RRs), mean differences (M... Overall, we included 70 trials in this review. Sample sizes ranged between 5 and 445 participants in each arm, and the total sample size per study ranged from 10 to 1168. Thirty-five studies included ... In terms of efficacy, SSRIs, SNRIs (venlafaxine), TCAs, MAOIs and BDZs may be effective, with little difference between classes. However, it is important to note that the reliability of these findings...

Thresholds for surfactant use in preterm neonates: a network meta-analysis.

To perform a network meta-analysis of randomised controlled trials of different surfactant treatment strategies for respiratory distress syndrome (RDS) to assess if a certain fraction of inspired oxyg... Systematic review and network meta-analysis using Bayesian analysis of randomised trials of prophylactic versus selective surfactant for RDS.... Cochrane Central Register of Controlled Trials, MEDLINE, Embase and Science Citation Index Expanded.... Randomised trials including infants under 32 weeks of gestational age.... Intratracheal surfactant, irrespective of type or dose.... Our primary outcome was neonatal mortality, compared between groups treated with selective surfactant therapy at different thresholds of FiO... Of 4643 identified references, 14 studies involving 5298 participants were included. We found no statistically significant differences between 30%, 40% and 50% FiO... Our results do not show a clear benefit of surfactant treatment at any threshold of FiO... CRD42020166620....

Common bile duct stones management: A network meta-analysis.

Timely management is critical for treating symptomatic common bile duct (CBD) stones; however, a single optimal management strategy has yet to be defined in the acute care setting. Consequently, this ... PubMed, SCOPUS, MEDLINE, Embase, and Cochrane Central Register of Controlled Trials were methodically queried for articles from 2010 to 2021. The search terms were a combination of medical subject hea... A total of 16 studies (8,644 participants) addressing the LOS and 41 studies (19,756 participants) addressing postprocedural complications were included in the analysis. The one-stage approaches were ... This network meta-analysis suggests that both laparoscopic CBD exploration and intraoperative ERCP have equally good outcomes and provide a preferable single-anesthesia patient pathway with a shorter ... Systematic Review/Meta Analysis; Level III....

Immunomodulators and immunosuppressants for progressive multiple sclerosis: a network meta-analysis.

In recent years a broader range of immunomodulatory and immunosuppressive treatment options have emerged for people with progressive forms of multiple sclerosis (PMS). While consensus supports these o... To compare through network meta-analysis the efficacy and safety of alemtuzumab, azathioprine, cladribine, cyclophosphamide, daclizumab, dimethylfumarate, diroximel fumarate, fingolimod, fludarabine, ... We searched CENTRAL, MEDLINE, and Embase up to August 2022, as well as ClinicalTrials.gov and the WHO ICTRP.... Randomised controlled trials (RCTs) that studied one or more treatments as monotherapy, compared to placebo or to another active agent, for use in adults with PMS.... Two review authors independently selected studies and extracted data. We performed data synthesis by pair-wise and network meta-analysis. We assessed the certainty of the body of evidence according to... We included 23 studies involving a total of 10,167 participants. The most frequent (39% of studies) reason for a rating of high risk of bias was sponsor role in study authorship and data management an... The number of people with PMS with relapses is probably slightly reduced with rituximab at two years, and interferon beta-1b at three years, compared to placebo. Both drugs are also probably associate...

Moist dressings in the treatment of pressure injuries: A network meta-analysis.

The aim of this network meta-analysis is to analyze the difference in therapeutic effects between moist dressings and traditional dressings in the treatment of pressure injury (PI), explore the healin... The incidence of pressure injury is high and the burden of disease is high, but there is no consensus on how to choose moist dressing treatment.... A systematic review with network meta-analysis was performed.... We searched the Chinese Biomedicine Literature Database and China National Knowledge Infrastructure, Wanfang Database, VIP database, PubMed, Web of Science, EMBASE.com, CENTRAL (Cochrane Central Regis... R studio software and Stata 16.0 software were used to compare different moist dressings and traditional dressings.... 41 RCTs of moist dressings in the treatment of PI were included. A total of seven kinds of moist dressings, Vaseline gauze and traditional gauze dressing were involved. All RCTs were at a medium to hi... The effect of moist dressings in treating PI is more advantageous than traditional dressings. However, in terms of direct cost and the number of dressings changes, more research is needed to improve t... This study is a network meta-analysis, which does not require the participation of patients and the public....